Next Article in Journal
Monitoring Pharmacological Treatment of Breast Cancer with MRI
Previous Article in Journal
Identification and Validation of a Macrophage Phagocytosis-Related Gene Signature for Prognostic Prediction in Colorectal Cancer (CRC)
Previous Article in Special Issue
Chemical Composition of Clove and Fennel Seed Essential Oils and a Comparison of Their In Silico and In Vitro Antibacterial Activity with That of Their Main Compounds
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Brief Report

Effects of Eucommia ulmoides Oliver Extracts on Odontoblast Differentiation in Human Dental Pulp Stem Cells

1
Department of Dental Pharmacology, School of Dentistry, Pusan National University, 49, Busandaehak-ro, Yangsan-si 50612, Gyeongsangnam-do, Republic of Korea
2
Dental and Life Science Institute, School of Dentistry, Pusan National University, 49, Busandaehak-ro, Yangsan-si 50612, Gyeongsangnam-do, Republic of Korea
3
Department of Pharmacology, College of Dentistry, Jeonbuk National University, Jeonju-si 54896, Jeonbuk-do, Republic of Korea
*
Authors to whom correspondence should be addressed.
Curr. Issues Mol. Biol. 2025, 47(10), 805; https://doi.org/10.3390/cimb47100805
Submission received: 18 August 2025 / Revised: 20 September 2025 / Accepted: 22 September 2025 / Published: 1 October 2025

Abstract

Eucommia ulmoides Oliver (E. ulmoides), a traditional medicinal plant, has been widely used for its antioxidant and anti-inflammatory properties. However, its effects on dental tissue regeneration remain largely unexplored. In this study, we investigated the odontogenic potential of E. ulmoides extract in human dental pulp stem cells (hDPSCs). Cell viability was assessed using the cell counting kit-8 (CCK-8) assay, and antioxidant activity was evaluated via the DPPH radical scavenging method. Odontoblast differentiation was examined using Alizarin Red S (ARS) staining, real-time PCR, and Western blot analysis of key differentiation markers, including dentin matrix protein 1 (DMP-1) and dentin sialophosphoprotein (DSPP). Our results demonstrated that E. ulmoides extract enhanced mineralization and upregulated both gene and protein expression of odontoblast differentiation markers in a dose-dependent manner. Furthermore, signaling pathway analysis revealed that E. ulmoides extract activated the SMAD pathway while downregulating ERK and p38 MAPK phosphorylation during odontogenic differentiation. These findings suggest that E. ulmoides extract promotes odontoblast differentiation in hDPSCs and may serve as a promising natural agent for dental tissue regeneration. These findings further underscore its potential clinical relevance as a therapeutic candidate to enhance dental tissue repair and regeneration.

1. Introduction

Odontoblasts are post-mitotic cells located at the interface between dental pulp and dentin, where they are essential for the formation of primary and secondary dentin [1]. Loss or dysfunction of odontoblasts impairs dentin development, causes progressive dental tissue damage, and results in difficulties with mastication, thereby reducing patients’ quality of life [2]. Regeneration of odontoblasts is therefore a critical step in restoring normal oral function. Since the discovery in 2017 that glycogen synthase kinase-3β (GSK-3β) inhibitors can induce tooth regeneration [3], interest in developing novel strategies for dental tissue repair has increased.
Eucommia ulmoides Oliver (E. ulmoides), a deciduous tree of the family Eucommiaceae, is native to temperate and subtropical regions and is widely cultivated in Korea, China, and Japan [4]. Its bark has traditionally been used to strengthen muscles and lungs and to regulate blood pressure. Aqueous extracts have shown beneficial effects on hyperlipidemia and fatty liver disease and are often consumed as tea [5]. Phytochemical analyses have identified phenolics, flavonoids, lignans, iridoids, steroids, and triterpenes in its leaves and bark. Among these compounds, lignan glycosides such as glucopyranosides exhibit anti-obesity, anti-cardiovascular, and anti-hyperlipidemic properties [6,7]. Furthermore, E. ulmoides extracts have been reported to alleviate depression [8], improve reproductive and sexual function [9,10], prevent muscle atrophy related to central nervous system injury [11,12], and reduce the risk of osteoporosis [11]. Despite these systemic health benefits, studies on the potential of E. ulmoides for tooth regeneration remain limited.
Although E. ulmoides has been associated with systemic therapeutic effects, its role in odontoblast differentiation has not been fully clarified. The present study aimed to evaluate the antioxidative properties of E. ulmoides extract and its ability to promote odontoblast differentiation in human dental pulp stem cells (hDPSCs). Odontogenic differentiation was assessed using Alizarin Red S (ARS) staining, real-time PCR, and Western blotting of odontoblast-specific markers. In addition, signaling pathways associated with odontogenic induction were examined. The phytochemical profile of the extract was further analyzed by ultra-performance liquid chromatography coupled with tandem mass spectrometry (UPLC–MS/MS). Together, these findings demonstrate that E. ulmoides extract enhances odontoblast differentiation and may represent a promising natural candidate for dental tissue engineering.

2. Materials and Methods

2.1. Cell Culture

hDPSCs were purchased from Lonza (PT-5025; Basel, Switzerland). The cells were cultured in StemMACSTM MSC Expansion Media Kit XF (Miltenyi Biotec., Inc., Somerville, MA, USA) under a humidified atmosphere containing 5% CO2 at 37 °C. The medium was changed every 3 days.

2.2. Reagents

DPPH (Santa Cruz Biotechnology, Santa Cruz, CA, USA), CCK-8 assay kit (Abbkine, Atlanta, GA, USA), DMSO, α-MEM, and FBS (Gibco, Thermo Fisher Scientific, Waltham, MA, USA) were employed in this study. Antibiotic–antimycotic solution and PBS were obtained from Biowest (Nuaillé, France), and RIPA lysis buffer was supplied by iNtRON Biotechnology (Seongnam-si, Republic of Korea). Primary antibodies against phospho-SMAD 1/5 and total SMAD 1/5 were purchased from Thermo Fisher Scientific. DMP-1, DSPP, osteopontin (OPN), and β-actin were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA), and the peroxidase-conjugated secondary antibodies were purchased from Enzo Corp. (New York, NY, USA).

2.3. Cell Viability Assay

To evaluate the effect of E. ulmoides extract on hDPSCs, the cells were first seeded into a 96-well plate at 2 × 104 cells/well, E. ulmoides extract was added at concentrations of 10, 25, or 50 μg/mL, and the cells were then cultured for 72 h. These concentrations were selected because treatment above 50 μg/mL markedly reduced cell viability to below 50%, making higher concentrations unsuitable for subsequent experiments. After culturing, 10 μL of CCK-8 in 100 μL of α-MEM without FBS was added, and the culture was incubated for 2 h at 37 °C in a 5% CO2 incubator. Absorbance was then estimated using an enzyme-linked immunosorbent assay reader (Tecan, Männedorf, Switzerland) at a wavelength of 450 nm.

2.4. Anti-Oxidation/Radical-Scavenging Activity

The DPPH radical scavenging assay was performed following the method of Barros et al. (2007) [13]. Absorbance was recorded at 517 nm, and the scavenging activity (%) was calculated using the following formula:
Scavenging activity (%) = [100 − {(AB − AS)/AB}] × 100,
where AB represents the absorbance of the DPPH control, and AS denotes the absorbance of the sample.

2.5. Odontogenic Differentiation

Odontogenic differentiation was induced by culturing the cells for 3 weeks in odontogenic medium (10% FBS, 0.1 mM dexamethasone, 10 mM β-glycerophosphate, and 50 mM ascorbic acid in α-MEM). Then, 2% ARS stain with a pH of 4.3 (Sigma-Aldrich, St. Louis, MO, USA) was used to estimate extracellular matrix calcification after 15 min. To quantify mineral deposition, 300 µL of 10% (w/v) cetylpyridinium chloride (CPC; Sigma-Aldrich), prepared in 10 mM sodium phosphate buffer (pH 7.0), was added to each stained well and incubated for 20 min at room temperature with gentle agitation to elute Alizarin Red S. The eluate was transferred to a 96-well plate, and absorbance was measured at 562 nm against a CPC buffer blank.

2.6. RNA Extraction and cDNA Synthesis

For total RNA extraction, human dental pulp stem cells were cultured in 6-well plates (1 × 106 cells/well), and odontoblast differentiation began after the confluency reached full density. After 7 and 21 days, the cells were harvested, and total cellular RNA was isolated using FavorPrep™ Tri-RNA reagent (Favorgen, Ping-Tung, Taiwan) according to the manufacturer’s instructions. cDNA was synthesized from total RNA (2 μg) using Accupower RT PreMix (Bioneer, Daejeon, Republic of Korea). The cDNA synthesis process consisted of two steps. First, the RNA was incubated with oligo dT, and then the cDNA was synthesized under the following conditions: 42 °C for 60 min and RTase inactivation at 94 °C for 5 min. The reaction was stopped by heating at 70 °C for 15 min.

2.7. Real-Time Quantitative PCR (RT-qPCR)

Power SYBR Green PCR Master Mix reagent (Thermo Fisher Scientific) was used for the real-time qPCR. The cDNA was diluted (1:10) in Power SYBR Green PCR Master Mix. The RT-qPCR was performed in 20 μL reactions that contained 5–20 ng cDNA, 1 μL of each primer (10 pM), and 10 μL Power SYBR Green PCR Master Mix using an ABI 7500 Instrument (Applied Biosystems, Warrington, UK). The data were analyzed using ABI software, v 2.0.5. (Applied Biosystems, Warrington, UK) and the values were determined using the ∆∆Ct method. The RT-qPCR primer sequences used in this experiment are listed in Table S1.

2.8. Western Blot Analysis

Cells were lysed in RIPA buffer (Sigma-Aldrich, St. Louis, MO, USA) supplemented with a protease inhibitor cocktail (Roche, Indianapolis, IN, USA) and phosphatase inhibitors. Extracted proteins were resolved by SDS-PAGE and subsequently transferred onto PVDF membranes (Millipore, Bedford, MA, USA). Membranes were incubated with specific primary antibodies, followed by HRP-conjugated secondary antibodies. Protein bands were detected using an enhanced chemiluminescence kit (Pierce Biotechnology, Rockford, IL, USA) and visualized with an LAS-4000 imaging system (Fujifilm, Tokyo, Japan). The primary and secondary antibodies employed in Western blotting are summarized in Table S2.

2.9. Extraction of E. ulmoides

E. ulmoides was obtained from Gwangmyeongdang (Ulsan, Republic of Korea). To prepare the extract, 200 g of dried material was immersed in 2 L of 99.8% methanol and gently agitated once daily for three days. The crude extract was filtered through 185 mm filter paper and concentrated under reduced pressure in a water bath. The concentrate was then lyophilized using a freeze dryer (Labconco, Kansas City, MO, USA), yielding 11.9%. The resulting powder was stored at −20 °C and subsequently dissolved in DMSO for in vitro experiments.

2.10. LC-MS/MS Analysis

This method was established based on manufacturer-recommended protocols from SCIEX and Waters. Metabolomic profiling was performed using a ZenoTOF ™ 7600 mass spectrometer (SCIEX, Framingham, MA, USA) coupled with an ExionLC™ UHPLC system (AB SCIEX, Redwood City, CA, USA).
Chromatographic separation was carried out on a Waters ACQUITY UPLC HSS T3 column (2.1 mm × 100 mm, 1.8 μm) maintained at 40 °C, with an injection volume of 5 μL and a flow rate of 0.3 mL/min.
Positive ion mode: The mobile phase consisted of water with 0.1% formic acid (A) and acetonitrile containing 0.1% formic acid (B).
Negative ion mode: The mobile phase consisted of 5 mM ammonium formate in water (A) and acetonitrile with 5 mM ammonium formate (B).
The gradient program, applied in both modes, was as follows:
0–1 min, 5% B; 1–12 min, 5–95% B; 12–14 min, 95% B; 14–14.1 min, 95–5% B; and 14.1–17 min, 5% B for column re-equilibration.
Mass spectrometry was performed in information-dependent acquisition (IDA) mode with the following parameters: ion spray voltage, +4500 V (positive)/−4500 V (negative); curtain gas (CUR), 35 psi; ion source gas 1 (GS1), 55 psi; ion source gas 2 (GS2), 60 psi; temperature, 550 °C; and scan range, m/z 50–1250.
MS/MS spectra were acquired using a collision energy of 35 ± 15 eV. Zeno trap pulsing was enabled during acquisition to enhance MS/MS sensitivity. The total running time was 30 min per sample.

2.11. Statistical Analysis

Data in graphs are presented as mean ± SEM of n independent experiments, as indicated in the figure legends. Since the dataset did not conform to a normal distribution, comparisons between E. ulmoides-treated groups and controls were performed using the Wilcoxon matched-pairs signed-rank test. Statistical significance was defined as * p < 0.05, ** p < 0.02, and *** p < 0.01.
LC-MS/MS table values report m/z, retention time (RT, min), and peak area (a.u.) from representative runs; no dispersion statistics were applied to these identification data.

3. Results

3.1. Effects of E. ulmoides Extract on Cell Proliferation and Anti-Oxidant Activity

A DPPH assay was performed to examine the antioxidant activity of E. ulmoides (Figure 1A). At a concentration of 10 μg/mL, the extract increased radical scavenging activity by approximately 20-fold compared with the control. At 25 μg/mL, the activity was enhanced nearly 40-fold, demonstrating a stronger antioxidant effect. These findings clearly indicate that the increase in DPPH radical scavenging activity was dependent on the concentration of E. ulmoides. Overall, these results suggest that E. ulmoides extract exerts potent, dose-dependent antioxidant effects.
Cell proliferation was evaluated using the CCK-8 assay after 72 h of treatment with E. ulmoides. At first, the hDPSCs were treated with high concentrations of E. ulmoides (10, 25, and 50 μg/mL), and there were no toxic effects on the cells. The ideal E. ulmoides concentration was determined by testing several concentrations of E. ulmoides (10, 25, and 50 μg/mL). The cells were treated with E. ulmoides for 72 h, and the results showed that the various concentrations had no effect on cell proliferation (Figure 1B).

3.2. Effects of E. ulmoides Extract on Mineralization in hDPSCs

Figure 1 shows that the E. ulmoides extract was not toxic to hDPSCs. Therefore, we measured mineralization during E. ulmoides extract-treated odontoblast differentiation. Figure 2 shows that odontoblast differentiation was induced in hDPSCs. ARS staining was performed to evaluate mineralization. In Figure 2A, the ARS staining is shown by well plate scanning; each well was imaged using a microscope, and the quantification data are presented in Figure 2B. Quantitative analysis of staining intensity is displayed in Figure 2C.
At 10 μg/mL, E. ulmoides extract produced a slight increase in mineral deposition compared with the control. Treatment with 25 μg/mL resulted in a clear enhancement of mineralized nodule formation, while 50 μg/mL produced the most extensive mineralization, consistent with the highest absorbance values measured. These findings indicate that the extent of mineralization increased in proportion to the concentration of E. ulmoides.
In summary, ARS staining confirmed that E. ulmoides extract promoted odontoblast differentiation in hDPSCs in a dose-dependent manner.

3.3. Odontoblast Differentiation Markers Expression in E. ulmoides Extract-Treated hDPSCs

We evaluated the expression of odontoblast markers to determine whether E. ulmoides extract accelerates odontoblast differentiation. Alkaline phosphatase (ALP) and runt-related transcription factor-2 (RUNX-2) were used as the early markers. DMP-1 and DSPP were also used in addition to these markers.
As shown in Figure 3A–E, real-time PCR was performed to evaluate the pluripotency of E. ulmoides extract toward odontoblasts. At 7 days of induction, ALP, RUNX-2, and bone morphogenetic protein 2 (BMP-2) expression as early and middle odontoblast differentiation markers was measured, whereas DMP-1 and DSPP expression was measured in the day 21 samples.
Western blotting was performed to evaluate OPN, DMP-1, and DSPP expression in day 21 samples, and the results showed that the E. ulmoides extract treatments upregulated the expression of these proteins (Figure 3F). These results indicate that E. ulmoides extract treatment upregulated odontoblast differentiation.

3.4. Signaling Pathway Analysis of E. ulmoides Extract-Treated Odontoblast Differentiation in hDPSCs

Mitogen-activated protein (MAP) kinases are an evolutionarily conserved family of serine/threonine kinases that constitute an interconnected signaling network. They play key roles in diverse cellular processes, including differentiation, apoptosis, and proliferation [2,14].
To investigate the role of MAPK signaling in E. ulmoides-mediated odontoblast differentiation, phosphorylation of MAPK proteins was assessed by Western blotting. Cells were pretreated as described above and subsequently exposed to E. ulmoides extract for 30 min during odontoblast induction. The results revealed that E. ulmoides extract reduced phosphorylation of ERK and p38 compared with the control (Figure 4A). Thus, treatment with E. ulmoides markedly suppressed p-ERK and p-p38 during odontoblast differentiation of hDPSCs. In contrast, phosphorylation of SMAD 1/5/8 was elevated following E. ulmoides treatment under odontogenic conditions (Figure 4B).

3.5. Quantitative and Qualitative LC-MS/MS Analysis of E. ulmoides

To confirm the presence of active ingredients in E. ulmoides, an LC-MS/MS analysis was performed using the following method. Table 1 shows the main components in the positive basic charge mode, and Table 2 shows the main components in the negative basic charge mode. Therefore, the qualitative analysis performed by LC-MS/MS is reliable.

4. Discussion

Dental health is closely related to nutrient intake, as it directly influences food consumption. Previous studies have shown a correlation between the number of natural teeth and human life expectancy [14]. This underscores the importance of maintaining oral health and forming good hygiene habits early in life. Still, once teeth are lost, therapeutic intervention becomes necessary. Dental implants and dentures are commonly used, but they cannot fully replace natural teeth and often present unresolved challenges, including biomechanical limitations and concerns about long-term stability [14].
The biological activity of E. ulmoides extract is likely related to its chemical composition. Compounds such as flavonoids, lignans, and iridoids are known to exert antioxidant effects, which can reduce oxidative stress in stem cells and create conditions favorable for differentiation. Oxidative stress has been shown to disrupt odontoblast differentiation by interfering with intracellular signaling, whereas antioxidants help restore redox balance and support lineage commitment. In this study, the extract displayed antioxidative activity alongside enhanced expression of odontoblast-associated genes and proteins, indicating that its phytochemical profile contributes to the observed cellular effects in hDPSCs [6,7,8].
To overcome the limitations of artificial replacements, we explored the potential of E. ulmoides extract to promote odontogenic differentiation in hDPSCs. E. ulmoides was chosen not only for its long history in herbal medicine but also because of reports suggesting regenerative effects on different tissues. In our study, methanol-based extraction was used to obtain a purified powder, which was applied to hDPSCs at 10, 25, and 50 μg/mL. Odontoblast differentiation was then evaluated by real-time PCR and western blotting of marker genes and proteins.
The results indicate that E. ulmoides extract enhances odontoblast differentiation and may be useful for dental tissue engineering. Comparable effects have been reported with other natural compounds. For example, resveratrol enhanced odontogenic differentiation of hDPSCs through SIRT1 and β-catenin activation [15]. Curcumin has been shown to promote mineralization via stimulation of the Wnt pathway [16], while green tea polyphenols such as EGCG increased odontoblast-like differentiation and mineral deposition [17]. These parallels suggest that E. ulmoides belongs to a broader class of plant-derived compounds with potential roles in dentin regeneration.
Mechanistically, our findings show that E. ulmoides extract modulates two major intracellular pathways associated with odontoblast differentiation. It suppressed ERK and p38 MAPK phosphorylation—commonly linked to cellular stress responses—while activating SMAD 1/5/8 signaling, a central pathway in odontogenic gene expression. Previous work has highlighted the importance of BMP2–SMAD signaling in odontoblast differentiation [18], and MAPK/ERK activity has also been recognized as a regulator of proliferation and differentiation [19]. This dual action indicates that E. ulmoides not only reduces inhibitory MAPK signals but also reinforces SMAD-mediated transcriptional activity, thereby promoting odontoblast lineage commitment.
LC-MS/MS analysis confirmed the presence of multiple bioactive molecules in the extract (Table 1 and Table 2). It is possible that these compounds act synergistically to produce the observed biological effects. Recent reviews emphasize that natural molecules, including flavonoids and lignans, can support dental pulp stem cell activity [20], and the phytochemical complexity of E. ulmoides itself has been well-documented [5]. Identifying the most active constituents, as well as establishing standardized extract preparations, will be important steps for translation into therapeutic use.
In summary, E. ulmoides extract promoted odontoblast differentiation in hDPSCs in a concentration-dependent manner and acted through modulation of MAPK and SMAD signaling pathways. Beyond its antioxidative and anti-inflammatory effects, the extract showed promise as a natural candidate for regenerative dentistry. These findings suggest that E. ulmoides extract could complement existing approaches not only in pulp and dentin regeneration but also in periodontal repair and preservation of pulp vitality. Strategies for physiological dentin regeneration are increasingly shifting toward biologically inspired approaches [21], and recent reviews highlight the feasibility of dental pulp regeneration for clinical application [22]. While our study was limited to in vitro experiments, further in vivo and preclinical studies will be required before clinical application can be realized.

5. Conclusions

In this study, Eucommia ulmoides extract was found to promote odontoblast differentiation of human dental pulp stem cells in a concentration-dependent manner. The extract enhanced the expression of odontoblast-related genes and proteins and influenced intracellular signaling by reducing ERK/p38 MAPK activity while activating SMAD 1/5/8 pathways. LC–MS/MS analysis revealed the presence of various phytochemicals, including flavonoids, lignans, and iridoids, which may contribute to these effects. Taken together, the findings indicate that E. ulmoides extract has potential as a natural agent for dental tissue regeneration. Further studies, including in vivo and preclinical experiments, will be needed to confirm these observations and to clarify the specific compounds responsible for the activity.

Supplementary Materials

The supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/cimb47100805/s1.

Author Contributions

Conceptualization, H.-O.J., J.-M.J., D.-S.K. and H.-R.K.; methodology, H.-O.J. and J.-M.J.; investigation, H.-O.J., J.-M.J. and S.-K.B.; validation, H.-O.J. and J.-M.J.; formal analysis, H.-O.J. and J.-M.J.; data curation, H.-O.J. and J.-M.J.; writing—original draft preparation, D.-S.K.; writing—review and editing, D.-S.K. and H.-R.K.; visualization, S.-K.B.; supervision, H.-R.K.; project administration, H.-R.K.; funding acquisition, D.-S.K. and H.-R.K. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea Government (MSIT) (2023R1A2C2003446, RS-2023-00225239).

Data Availability Statement

hDPSCs were purchased from Lonza (PT-5025; Basel, Switzerland). The original contributions presented in this study are included in the article/Supplementary Material. Further inquiries can be directed to the corresponding author(s).

Acknowledgments

The authors gratefully acknowledge the financial support of the National Research Foundation of Korea (NRF) grant funded by the Korea Government (MSIT).

Conflicts of Interest

The authors declare that they have no competing financial interests or personal relationships that could have influenced the work reported in this paper.

Abbreviations

E. ulmoidesEucommia ulmoides Oliver
CCK-8Cell counting kit-8
ALPAlkaline phosphatase
RUNX-2Runt-related transcription factor 2
OPNOsteopontin
DMP-1Dentin matrix acidic phosphoprotein 1
DSPPDentin sialophosphoprotein
ERKExtracellular signal-regulated kinase
JNKc-Jun NH2 terminal kinase
MAP kinaseMitogen-activated protein kinase
SMADMothers against decapentaplegic homolog

References

  1. Jang, H.-O.; Ahn, T.-Y.; Ju, J.-M.; Bae, S.-K.; Kim, H.-R.; Kim, D.-S. Odontogenic Differentiation-Induced Tooth Regeneration by Psoralea corylifolia L. Curr. Issues Mol. Biol. 2022, 44, 2300–2308. [Google Scholar] [CrossRef] [PubMed]
  2. Lampiasi, N. The Migration and the Fate of Dental Pulp Stem Cells. Biology 2023, 12, 742. [Google Scholar] [CrossRef] [PubMed]
  3. Neves, V.C.; Babb, R.; Chandrasekaran, D.; Sharpe, P.T. Promotion of natural tooth repair by small molecule GSK3 antagonists. Sci. Rep. 2017, 7, 39654. [Google Scholar] [CrossRef] [PubMed]
  4. Lee, G.H.; Lee, H.Y.; Choi, M.K.; Choi, A.H.; Shin, T.S.; Chae, H.J. Eucommia ulmoides leaf (EUL) extract enhances NO production in ox-LDL-treated human endothelial cells. Biomed. Pharmacother. 2018, 97, 1164–1172. [Google Scholar] [CrossRef]
  5. Huang, L.; Lyu, Q.; Zheng, W.; Yang, Q.; Cao, G. Traditional application and modern pharmacological research of Eucommia ulmoides Oliv. Chin. Med. 2021, 16, 73. [Google Scholar] [CrossRef]
  6. Kim, H.H.; Ahn, S.H.; Park, S.Y. Effects of Eucomiae Cortex on the Depression of Male Aged Mice. J. Physiol. Pathol. Korean Med. 2019, 33, 10–16. [Google Scholar] [CrossRef]
  7. Yao, L.; Zhang, A.; Zhang, H.; Shao, J.; Wen, M.; Wang, C.; Jiang, H.; Li, M. Effects of Dietary Aqueous Extract from Eucommia ulmoides Oliver on Growth, Muscle Composition, Amino Acid Composition and Fatty Acid Composition of Rainbow Trout (Oncorhynchus mykiss). Pak. J. Zool. 2020, 53, 603–611. [Google Scholar] [CrossRef]
  8. Youn, Y.; Baek, H.I.; Jin, H.Y.; Jeong, D.Y.; Shen, L.; Joo, J.C.; Park, S.J. Randomized double-blind human trial to evaluate efficacy and safety of Rhus verniciflua Stokes (Lacca Sinica Exsiccata) and Eucommia ulmoides Oliver (Eucommiae cortex) extract combination (ILF-RE) on improvement of liver function. Korea J. Herbol. 2020, 35, 45–55. [Google Scholar]
  9. Yoon, S.J.; Kim, K.Y.; Kim, G.Y.; Nam, K.W.; Sim, K.C.; Kim, E.J.; Chung, H.W.; Kim, H.W.; Kim, G.D. Effects of Eucommia ulmoides Oliver and Treadmill Exercise on the Osteoporosis of Rats Caused by Glucocorticoid Induction. J. Physiol. Pathol. Korean Med. 2008, 22, 884–890. [Google Scholar]
  10. Yun, D.Y.; Park, S.H.; Lee, J.S. Effects of Eucommiae cortex on Myofiber Type Transition and MyoD Expression in Hind Limb Muscle Atrophy of Rats. J. Korean Med. Rehabil. 2008, 18, 47–63. [Google Scholar]
  11. Yamada, M.; Nagayama, M.; Miyamoto, Y.; Kawano, S.; Takitani, Y.; Tanaka, M.; Ehara, M.; Nakao, J.; Ochiai, T.; Shibukawa, Y.; et al. Mineral Trioxide Aggregate (MTA) Upregulates the Expression of DMP1 in Direct Pulp Capping in the Rat Molar. Materials 2021, 14, 4640. [Google Scholar] [CrossRef]
  12. Sun, Y.; Liu, W.Z.; Liu, T.; Feng, X.; Yang, N.; Zhou, H.F. Signaling pathway of MAPK/ERK in cell proliferation, differentiation, migration, senescence and apoptosis. J. Recept. Signal Transduct. Res. 2015, 35, 600–604. [Google Scholar] [CrossRef]
  13. Barros, L.; Ferreira, M.-J.; Queirós, B.; Ferreira, I.C.F.R.; Baptista, P. Total phenols, ascorbic acid, β-carotene and lycopene in Portuguese wild edible mushrooms and their antioxidant activities. Food Chem. 2007, 103, 413–419. [Google Scholar] [CrossRef]
  14. Schierz, O.; Baba, K.; Fueki, K. Functional oral health-related quality of life impact: A systematic review in populations with tooth loss. J. Oral Rehabil. 2021, 48, 256–270. [Google Scholar] [CrossRef] [PubMed]
  15. Li, Z.Y.; Li, X.L.; Wei, P.G.; Qu, L.; Qiu, L.H.; Yu, Y.Q. Regulation mechanism of resveratrol on odontogenic differentiation of human dental pulp stem cells. Shanghai J. Stomatol. 2023, 32, 132. [Google Scholar]
  16. Amir, M.; Jeevithan, L.; Barkat, M.; Fatima, S.H.; Khan, M.; Israr, S.; Rahman, S.U. Advances in regenerative dentistry: A systematic review of harnessing Wnt/β-catenin in dentin–pulp regeneration. Cells 2024, 13, 1153. [Google Scholar] [CrossRef] [PubMed]
  17. Li, Y.; Cheng, L.; Li, M. Effects of green tea extract epigallocatechin-3-gallate on oral diseases: A narrative review. Pathogens 2024, 13, 634. [Google Scholar] [CrossRef]
  18. Bai, Y.; Cheng, X.; Liu, X.; Guo, Q.; Wang, Z.; Fu, Y.; Yu, Q. Transforming growth factor-β1 promotes early odontoblastic differentiation of dental pulp stem cells via activating AKT, ERK1/2 and p38 MAPK pathways. J. Dent. Sci. 2023, 18, 87–94. [Google Scholar] [CrossRef]
  19. Wen, X.; Jiao, L.; Tan, H. MAPK/ERK pathway as a central regulator in vertebrate organ regeneration. Int. J. Mol. Sci. 2022, 23, 1464. [Google Scholar] [CrossRef]
  20. Calabrese, E.J.; Agathokleous, E.; Dhawan, G.; Kapoor, R.; Calabrese, V. Human dental pulp stem cells and hormesis. Ageing Res. Rev. 2022, 73, 101540. [Google Scholar] [CrossRef]
  21. Lee, M.; Lee, Y.S.; Shon, W.J.; Park, J.C. Physiologic dentin regeneration: Its past, present, and future perspectives. Front. Physiol. 2023, 14, 1313927. [Google Scholar] [CrossRef]
  22. Al-Masoody, A.H.; Hodjat, M.; Kashi, T.S.J. Hyaluronic acid as a biomaterial for dental pulp regeneration: A systematic review of preclinical studies. Front. Bioeng. Biotechnol. 2025, 13, 1661188. [Google Scholar] [CrossRef]
Figure 1. Antioxidant activity and the effects of E. ulmoides extract on cell proliferation. (A) A DPPH assay was performed, and the results indicated that the 10 µg/mL E.ulmoides extract-treated group showed a 20% increase in antioxidant activity. Antioxidant activity increased in a dose-dependent manner. (B) hDPSCs were incubated with 10, 25, or 50 µg/mL E. ulmoides extract for 72 h. Cell proliferation was measured using a CCK-8 assay. All data are presented as the mean ± SEM (n = 5). * p < 0.05, *** p < 0.01.
Figure 1. Antioxidant activity and the effects of E. ulmoides extract on cell proliferation. (A) A DPPH assay was performed, and the results indicated that the 10 µg/mL E.ulmoides extract-treated group showed a 20% increase in antioxidant activity. Antioxidant activity increased in a dose-dependent manner. (B) hDPSCs were incubated with 10, 25, or 50 µg/mL E. ulmoides extract for 72 h. Cell proliferation was measured using a CCK-8 assay. All data are presented as the mean ± SEM (n = 5). * p < 0.05, *** p < 0.01.
Cimb 47 00805 g001
Figure 2. Effect of E. ulmoides extract on the odontoblastic differentiation of hDPSCs. (A) ARS staining of differentiated odontoblasts. (B) Representative microscope images showing differentiation. (C) Quantification of ARS staining. All data are presented as the mean ± SEM (n = 5). *** p < 0.01.
Figure 2. Effect of E. ulmoides extract on the odontoblastic differentiation of hDPSCs. (A) ARS staining of differentiated odontoblasts. (B) Representative microscope images showing differentiation. (C) Quantification of ARS staining. All data are presented as the mean ± SEM (n = 5). *** p < 0.01.
Cimb 47 00805 g002
Figure 3. Effect of E. ulmoides extract on odontoblastic differentiation (OD) markers. (AE) mRNA expression levels of various OD markers (n = 3). (F) Immunoblotting using antibodies against OPN, DSPP, and DMP-1. All data are presented as the mean ± SEM (n = 5). * p < 0.05, ** p < 0.02, *** p < 0.01.
Figure 3. Effect of E. ulmoides extract on odontoblastic differentiation (OD) markers. (AE) mRNA expression levels of various OD markers (n = 3). (F) Immunoblotting using antibodies against OPN, DSPP, and DMP-1. All data are presented as the mean ± SEM (n = 5). * p < 0.05, ** p < 0.02, *** p < 0.01.
Cimb 47 00805 g003
Figure 4. Effects of E. ulmoides extract on MAPK signaling pathways. hDPSCs were pre-treated with E. ulmoides extract (10, 25, or 50 μg/mL) for 30 min. Western blotting was used to detect phosphorylation levels of (A) phospho ERK, phospho JNK, and phospho p38, compared with their total protein levels. (B) Immunoblotting using antibodies against phospho SMAD 1/5/8 and total SMAD 1/5/9.
Figure 4. Effects of E. ulmoides extract on MAPK signaling pathways. hDPSCs were pre-treated with E. ulmoides extract (10, 25, or 50 μg/mL) for 30 min. Western blotting was used to detect phosphorylation levels of (A) phospho ERK, phospho JNK, and phospho p38, compared with their total protein levels. (B) Immunoblotting using antibodies against phospho SMAD 1/5/8 and total SMAD 1/5/9.
Cimb 47 00805 g004
Table 1. Representative metabolites identified from E. ulmoides extract using LC-MS/MS in positive ionization mode.
Table 1. Representative metabolites identified from E. ulmoides extract using LC-MS/MS in positive ionization mode.
No.Compoundm/zRT (min)Area (a.u.)ScoreFormula
1L-Sorbose203.05390.921,505,000100C8H10O6
2Glycerophosphocholine258.11170.89209,00098.9C7H19N3O5S
3Maltotriose522.20580.96339,00095.8C5H20N20O9
41-Kestose543.13530.96204,00097.1C29H24N6OS
56.α.-Mannobiose325.11480.96112,00085.6C6H16N10O4S
6Stachyose689.21490.96165,00081.8C18H32N20O4S3
7Loganic acid399.12812.75138,000100C16H10N14
8Coniferyl aldehyde179.0706488,40072.9C10H10O3
9Coumarin147.04434.1294,20056C9H6O2
10Aspyrone185.08114.1171,00083.8C9H12O4
11Swertiamarin397.11384.79354,00090.5C19H24O5S2
12Catalpol385.164.15109,00078.5C29H20O
13Tetrahydrocurcumin355.13755.1895,00092.5C14H22N6OS2
14Phenylacetaldehyde121.06534.7951,00088.6C8H8O
15Hydrocinnamic acid151.07564.93126,00092C9H10O2
16Methyl trans-cinnamate163.07555.4630,00094.7C10H10O2
17Anisaldehyde137.064.7225,60051.5C8H8O2
18Eleutheroside E760.30746.59176,00098.7C15H30N30O5S
19Aspyrone (replicate)185.08117.0378,00087.6C8H8O3
20Swertiamarin (replicate)385.164.16109,00078.5C29H20O
m/z: mass-to-charge ratio; RT: retention time (min); Area: peak area (a.u.).
Table 2. Representative metabolites identified from E. ulmoides Oliver extracts using LC-MS/MS in negative ionization mode.
Table 2. Representative metabolites identified from E. ulmoides Oliver extracts using LC-MS/MS in negative ionization mode.
No.Compoundm/zRT (min)Area (a.u.)ScoreFormula
1Syringic acid197.04882.3550,00089.1C6H14O5S
2Vanillic acid167.03761.6344,38099.3C5H12O4S
3Geniposidic acid373.12050.9818,66097.1C15H18N8O2S
4D-(+)-Raffinose503.16982.0130,37093.7C26H20N10O2
5Hexadecanedioic acid285.21079.2376,360100.0C14H30N4S
6Asperuloside413.15023.87103,60097.1C14H18N14S
7Caffeic acid179.03782.8724,64096.9C6H12O4S
8Chlorogenic acid353.09381.0214,000100C7H12N14O5
9Aucubin345.12504.0367,02096.2C6H14N14O4
10Melibiose341.11490.9793,38099.2C11H18N8O3S
11Trehalose387.12120.9723,00099.3C4H18N14OS2
12Sucrose683.23650.97138,00054.6C18H18N2O5
13D-Glucose225.06530.988,45095.1C4H12N4O2S
143-Furancarboxylic acid253.14814.7292,88081.0C4H18N10O3
15Neochlorogenic acid353.16525.60103,60095.0C8H22N10O6
16Genipin225.08036.0790,16098.6C8H18O5S
173-Hydroxy-9,10-dimethoxypterocarpan299.09647.2231,46093.7C7H22N6O4S2
18(+)-Pinoresinol357.13919.7312,50098.5C8H26N10O6
19Pinoresinol-glucoside357.13957.6071,91099.5C3H20N16O4S
203,5-Dicaffeoyl quinic acid515.122626.19264,400100.0C7H12O6
m/z: mass-to-charge ratio; RT: retention time (min); Area: peak area (a.u.).
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Jang, H.-O.; Ju, J.-M.; Bae, S.-K.; Kim, D.-S.; Kim, H.-R. Effects of Eucommia ulmoides Oliver Extracts on Odontoblast Differentiation in Human Dental Pulp Stem Cells. Curr. Issues Mol. Biol. 2025, 47, 805. https://doi.org/10.3390/cimb47100805

AMA Style

Jang H-O, Ju J-M, Bae S-K, Kim D-S, Kim H-R. Effects of Eucommia ulmoides Oliver Extracts on Odontoblast Differentiation in Human Dental Pulp Stem Cells. Current Issues in Molecular Biology. 2025; 47(10):805. https://doi.org/10.3390/cimb47100805

Chicago/Turabian Style

Jang, Hye-Ock, Ji-Min Ju, Soo-Kyung Bae, Da-Sol Kim, and Hyung-Ryong Kim. 2025. "Effects of Eucommia ulmoides Oliver Extracts on Odontoblast Differentiation in Human Dental Pulp Stem Cells" Current Issues in Molecular Biology 47, no. 10: 805. https://doi.org/10.3390/cimb47100805

APA Style

Jang, H.-O., Ju, J.-M., Bae, S.-K., Kim, D.-S., & Kim, H.-R. (2025). Effects of Eucommia ulmoides Oliver Extracts on Odontoblast Differentiation in Human Dental Pulp Stem Cells. Current Issues in Molecular Biology, 47(10), 805. https://doi.org/10.3390/cimb47100805

Article Metrics

Article metric data becomes available approximately 24 hours after publication online.
Back to TopTop